| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 48,655 | 58,010 | 59,492 | 52,796 | | Cost of Revenue | (1,229) | 622 | 607 | 19,538 | | | Gross Profit |
-
| 57,388 | 58,885 | 33,258 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 42,600 | 46,278 | 44,694 | 33,482 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 6,733 | 5,963 | 8,151 | 1,646 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,697) | 5,147 | 6,040 | (1,870) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 550 | 5,147 | 6,040 | (1,870) | | Interest Expense | 483 | 663 | 1,100 | 1,704 | | Income Before Tax | 66 | 4,484 | 4,940 | (3,574) | | Income Tax Expense | 3 | 1,394 | 1,707 | (1,440) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 63 | 3,090 | 3,233 | (2,133) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 63 | 3,090 | 3,233 | (2,133) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $63 | $3,090 | $3,233 | ($2,133) |
|
0.22% Nasdaq 
0.23 (6.13%) 
Income Statement
